Talentia Software Acquires Swiss Company Addedo
Talentia Software , leading provider of HR and Financial Performance enterprise software, accelerates its international development through the acquisition of Swiss company Addedo . This acquisition is an integral part of Talentia Software’s strategy to extend its lead in Corporate Performance Management (CPM) software and become a key European player on this market.
Switzerland, Zug-based Addedo is an IT consultancy firm specialized in Corporate Performance Management (CPM) services and applications. Addedo consulting services focus on the implementation of CPM software, covering key functions such as financial consolidation, budgeting, planning, reporting and analytics. Addedo also acts as an independent licensed reseller for market leading CPM software solutions, offering maintenance and support services to its clients. With close to 11 Million euros in sales, about 25 employees and 200 clients –among which many publically listed corporations-, Addedo has offices in Switzerland, Germany and Canada.
With more than 55 Million euros in sales (2016), Talentia Software has operations in France, the UK, Italy, Spain, Portugal and Greece. Consistent with the company’s acquisition strategy, this external growth opportunity enables Talentia Software to establish a physical presence and expand operations in the countries served by Addedo. This acquisition will also greatly enhance the activity and expertise of its Financial Performance product line.
Addedo is a licensed reseller for IBM Cognos (ESA Partner) and Longview, providing implementation, maintenance and support services to its clients. As part of this acquisition, Addedo will keep operating under its own brand, leveraging its strong partnerships and awareness to expand on its markets. This acquisition will also leverage a natural complementarity and help realize strong synergies between Talentia Software, a software provider and Addedo, an IT consulting, deployment and support services firm.
Michael Kempter will remain President of Addedo to lead Talentia Software’s operations in the DACH region (Germany Austria Switzerland) and the starting operations in North America, with the full support of his current management team. He is joining the Executive Board of Talentia Software and he will report directly to Viviane Chaine-Ribeiro.
Says Viviane Chaine-Ribeiro, President of Talentia Software: “This acquisition is a new critical step in our external growth strategy. It will further reinforce our market lead on the fast growing CPM market and accelerate our growth in countries such as Switzerland and Germany. It will also enable us to set foot in North America where Addedo recently opened an office. We are thrilled to join forces with Addedo, who achieved sustained growth over the years to reach a market-leading position today. Talentia Software will greatly benefit from Addedo’s insights and proven Financial Performance expertise, and in turn, we will be able to provide additional value to our clients and staff”.
Says Michael Kempter, President of Addedo: “We are pleased to join Talentia Software and merge our skills and capability. We share common values, including the commitment to delivering the highest quality of service to our clients. We will benefit from each other’s expertise, expand our current product portfolio and combine forces for the benefits of our client’s Financial Performance”.
About Talentia Software
With more than 3,600 customers in over 30 countries, Talentia Software is a market-leading European software provider of Finance software (Accounting, Financial Performance) and HR software (Payroll, Human Capital Management).
Talentia Software directly markets, deploys and supports its solutions in France, the UK, Spain, Portugal, Greece and Italy. The company also provides its solutions through a wide network of channel partners across Europe and South America.
For more information, please visit www.talentia-software.com
Follow us on social networks:
https://twitter.com/TalentiaSW
https://www.linkedin.com/company/talentia-software/
https://www.facebook.com/TalentiaSoftware/
https://www.youtube.com/channel/UCeLQ-XnQgae6lAKJU4yw1-A/videos
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180111005095/en/
Contact information
Media Relations:
Wellcom
Agency
Ingrid Zémor, + (331) 46 34 60 60
ingrid.zemor@wellcom.fr
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Corona Global Named Most Valuable Beer Brand in Kantar BrandZ Rankings for Second Consecutive Year15.5.2025 07:01:00 EEST | Press release
Corona has been recognized as the most valuable beer brand in the world for the second consecutive year in Kantar's BrandZ 2025 Most Valuable Global Brands report, released today. Eight out of the 10 most valuable global beer brands belong to AB InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD), according to the report ranking the top brands in the world. In 2024 AB InBev produced all-time high revenue and 15% Underlying EPS growth. The year marked double-digit growth for Corona outside of its home market of Mexico and triple-digit growth of its no-alcohol brand Corona Cero. Corona Cero is the first beer brand to sponsor the Olympic Games making its debut in Paris 2024. In 2025, Corona is celebrating its 100-year anniversary with events all over the world through its “Corona 100” platform. Corona is followed by Budweiser, the second most valuable beer brand in the world. Michelob ULTRA moved up one spot to #5 amongst beer brands globally. Michelob ULTRA has also been named the winner
Forrester Opens Nominations For Its 2025 B2B Awards In EMEA And APAC15.5.2025 07:00:00 EEST | Press release
Forrester (Nasdaq: FORR) today opened calls for nominations for its 2025 B2B Return On Integration Honors and B2B Programs Of The Year Awards in Asia Pacific (APAC) and Europe, Middle East, and Africa (EMEA). These awards will recognize B2B organizations based in both regions for achieving functional excellence and outstanding alignment across marketing, sales, and product — the B2B revenue engine — to improve customer experience and drive growth. Nominations for both award categories are open to organizations of all sizes in each region. B2B leaders across APAC and EMEA — including chief marketing officers, chief sales officers, chief product officers, and other marketing, sales, and product leaders — are invited and encouraged to apply. To be eligible, programs need to be developed by leaders and teams based in the APAC or EMEA regions. The nomination criteria for the two awards are as follows: B2B Return On Integration (ROI) Honors. These awards showcase organizations that have achi
Microba Announces Landmark GI Study Results From Over 4,600 Patients15.5.2025 05:12:00 EEST | Press release
Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”), a precision microbiome company, today announces preliminary results from the analysis of over 4,600 MetaXplore™ GI Plus test results, a comprehensive test for the assessment and management of lower gastrointestinal disorders, spanning symptoms including chronic pain, bloating, constipation, or diarrhea. This study demonstrates that MetaXplore can support clinicians to identify and address underlying gut issues that often go undetected by conventional testing. In over 70% of cases, the test revealed findings, such as abnormalities in gut bacteria, signs of infection, markers of inflammation or insufficiency that could inform targeted treatment strategies. Further, two-thirds of MetaXplore patients in a separate study of follow up survey results reported improvement of symptoms after their care was guided by the test results. This press release features multimedia. View the full release here: https://www.businesswire.
Bloomstreet Enters into Strategic Partnership Agreement with Google Israel for Market Expansion in Japan15.5.2025 05:00:00 EEST | Press release
Bloomstreet Inc. (Headquarters: Chuo-ku, Tokyo; President & CEO: Junichi Takayama; hereinafter “Bloomstreet”), a company that supports overseas enterprises entering the Japanese market, is pleased to announce a strategic partnership agreement with Google Israel Ltd. (Headquarters: Tel Aviv District; Country Manager: Barak Regev; hereinafter “Google Israel”). This partnership aims to support Israeli companies that operate globally with Google Ads and are seeking to expand into the Japanese market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250514387485/en/ How do Bloomstreet and Google Israel collaborate? The partnership between Bloomstreet and Google Israel is designed to support Israeli companies seeking to expand into the Japanese market by optimizing their website UI/UX, thereby enhancing the effectiveness of their Google Ads campaigns. Background of the Partnership Known as a "Start-up Nation," Israel is home to many
Rubedo Life Sciences’ Drug Discovery Platform, ALEMBIC™, Helps Identify Senescent or “Zombie” Neurons in New Study Linking Neuropathic Pain and Aging Published in Peer-Reviewed Scientific Journal Nature Neuroscience15.5.2025 04:11:00 EEST | Press release
Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation medicines targeting aging cells, today announced that using open source codes integrated in the company’s broader propriety drug discovery platform, ALEMBIC™, helped to identify senescent neurons in a new study that found senescent neurons drive chronic pain with injury and age.1 Senescent cells, often called “zombie” cells, arise as the results of cellular stress and damage. These senescent cells do not die but undergo cellular changes, including secreting pro-inflammatory factors, thereby potentially contributing to inflammatory responses within the body.1 The study, led by Stanford University scientists, Vivianne Tawfik, MD, PhD, and Lauren Donovan, PhD, and co-authored by Rubedo team members, including Chief Scientific Officer Marco Quarta, PhD, and Chief Technology Officer Alex Laslavic, was published in the May 14th edition of Nat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom